首页> 外文OA文献 >Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: the ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials

【2h】

Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: the ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials

机译：勃起功能障碍预测接受替米沙坦，雷米普利或两者的高风险患者的心血管事件：持续使用替米沙坦和联合雷米普利全球终点试验/替米沙坦随机评估aCE不耐受心血管疾病患者（ONTaRGET / TRaNsCEND）试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Böhm, Michael; Baumhäkel, Magnus; Teo, Koon; Sleight, Peter; Probstfield, Jeffrey; Gao, Peggy; Mann, Johannes F.; Diaz, Rafael; Dagenais, Gilles R.; Jennings, Garry L. R.; Liu, Lisheng; Jansky, Petr; Yusuf, Salim; Czuriga, István;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both: The ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant Subjects With Cardiovascular Disease (ONTARGET/TRANSCEND) Trials [J] . M. Bohm, M. Baumhakel, K. Teo, The Journal of Urology . 2010,第4aPta1of2期

机译：勃起功能障碍可预测接受替米沙坦，雷米普利或同时接受这两种药物的高危患者的心血管事件：正在进行中的替米沙坦单独治疗以及与雷米普利全球终点试验/替米沙坦的随机评估一起在ACE耐受性心血管疾病受试者中进行（ONTARGET / TRANSCEND）
2. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials. [J] . Bohm M, Baumhakel M, Teo K, Circulation: An Official Journal of the American Heart Association . 2010,第12期

机译：勃起功能障碍预测接受Telmisartan，Ramipril或两者的高风险患者的心血管事件：独自的替代替兰坦，并与Ramipril Global Endpoint试验/ Telmisartan随机评估研究中的ACE不宽容受试者（Ontarget / Transcend）试验组合。
3. Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: Substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) [J] . Bohm M, Baumhakel M, Probstfield JL, The American heart journal . 2007,第1期

机译：心血管高危患者的性功能，满意度以及勃起功能障碍与心血管疾病和危险因素的关联：正在进行中的替米沙坦单独研究以及与雷米普利全球终点试验/替米沙坦的随机评估研究相结合，用于ACE耐受的心血管疾病患者（目标/超越）
4. Effects of oral fixed-dose combinations of telmisartan plus ramipril and losartan plus ramipril in hypertension: A multicenter prospective randomized double-blind phase iii trial in adult indian patients [O] . S.D. Jain, Sangram Biradar, I. Periyandavar, 2005

机译：替米沙坦联合雷米普利和氯沙坦联合雷米普利口服固定剂量治疗高血压的成年印度裔患者的多中心前瞻性随机双盲III期试验
5. Impact of Sex on Cardiovascular Outcome in Patients at High Cardiovascular Risk Analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects With Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET) [O] . Kappert, Kai, Boehm, Michael, Schmieder, Roland, 2012

机译：性别对高心血管风险患者心血管结局的影响分析：替米沙坦随机评估研究的ACE耐受性心血管疾病患者（TRANSCEND）和持续进行的替米沙坦单独治疗，以及联合雷米普利全球终点试验（ONTARGET）

著录项

相似文献

相关主题

期刊订阅